Clinical Trials Browser

Phase 2 × Has results × Non-Squamous Non-Small Cell Lung Cancer × Clear all

NCT00760929 2021-01-05

A Study of the Effect of R1507 in Combination With Tarceva (Erlotinib) on Progression-Free Survival in Patients With Stage IIIb/IV Non-Small Cell Lung Cancer (NSCLC).

Phase 2 Terminated

171 enrolled 17 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01260181 2018-10-31

A Study of Erlotinib in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations

Phase 2 Completed

30 enrolled 13 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01174563 2018-09-17

A Study on the Correlation Between Tarceva (Erlotinib) - Induced Rash and Efficacy in EGFR Mutated Participants With Advanced Non-Small Cell Lung Cancer Receiving First-Line Therapy

Phase 2 Completed

60 enrolled 9 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01310036 2018-09-12

A Study of Tarceva (Erlotinib) as First Line Therapy in Participants With Non-Small Cell Lung Cancer Harbouring Epidermal Growth Factor Receptor (EGFR) Mutations

Phase 2 Completed

208 enrolled 12 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01378962 2018-01-23

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (TRIGGER)

Phase 2 Completed

50 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT02774278 2016-08-08

MERIT

Phase 2 Completed

264 enrolled 9 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00642473 2016-05-23

MATER

Phase 2 Completed

34 enrolled 8 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT00518011 2016-05-16

A Study of Tarceva (Erlotinib) and Gemcitabine in Treatment-Naive Patients With Advanced Non-Small Cell Lung Cancer.

Phase 2 Completed

17 enrolled 15 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01250119 2016-03-14

A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients.

Phase 2 Completed

688 enrolled 10 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01372384 2016-02-02

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations

Phase 2 Completed

6 enrolled 9 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01204697 2015-11-16

A Study of Erlotinib [Tarceva] as Monotherapy or Intermittent Dosing With Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. (TALISMAN)

Phase 2 Completed

74 enrolled 12 charts

Non-Squamous Non-Small Cell Lung Cancer

NCT01077713 2015-10-08

A Study of Avastin (Bevacizumab) in Combination With Gemcitabine With or Without Cisplatin in First-Line Treatment of Elderly Patients With Non-Small Cell Lung Cancer

Phase 2 Completed

86 enrolled 16 charts

Non-Squamous Non-Small Cell Lung Cancer